Faron Pharmaceuticals Oy Notification of Major Interest in Shares (8079L)

TIDMFARN TIDMAV.

RNS Number : 8079L

Faron Pharmaceuticals Oy

05 October 2016

 
 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 
---------------------------------------------------------------------------------------------------- 
 
 1. Identity of the issuer or                                     Faron Pharmaceuticals Oy 
  the underlying issuer 
  of existing shares to which 
  voting rights are 
  attached: (ii) 
---------------------------------------------------------------  ----------------------------------- 
 2 Reason for the notification (please tick the appropriate 
  box or boxes): 
---------------------------------------------------------------------------------------------------- 
 An acquisition or disposal of voting rights 
------------------------------------------------------------------  -------------------------------- 
 An acquisition or disposal of qualifying financial 
  instruments which may result in the acquisition 
  of shares already issued to which voting rights 
  are attached 
------------------------------------------------------------------  -------------------------------- 
 An acquisition or disposal of instruments with 
  similar economic effect to qualifying financial 
  instruments 
------------------------------------------------------------------  -------------------------------- 
 An event changing the breakdown of voting rights 
------------------------------------------------------------------  -------------------------------- 
 Other (please 
  specify): 
-----------------------------------------------------------  -----  -------------------------------- 
 3. Full name of person(s)                                      Aviva plc & its subsidiaries 
  subject to the 
  notification obligation: 
  (iii) 
-------------------------------------------------------------  ------------------------------------- 
 4. Full name of shareholder(s)                                 Registered Holder: 
  (if different from 3.):(iv) 
                                                                 BNY Norwich Union Nominees 
                                                                 Limited 122,189* 
 
                                                                 Chase (GA Group) Nominees 
                                                                 Limited 1,697,607* 
 
                                                                 State Street Nominees Limited 
                                                                 319,947* 
                                                                 * denotes direct interest 
                                                                 Chase (GA Group) Nominees 
                                                                 Limited 79,797 
                                                                 Chase Nominees Limited 52,129 
-------------------------------------------------------------  ------------------------------------- 
 5. Date of the transaction                                     03 October 2016 
  and date on 
  which the threshold is 
  crossed or 
  reached: (v) 
-------------------------------------------------------------  ------------------------------------- 
 6. Date on which issuer                                        04 October 2016 
  notified: 
-------------------------------------------------------------  ------------------------------------- 
 7. Threshold(s) that is/are                                    9% to 8% Change at Combined 
  crossed or                                                    Interest Level. Figures are 
  reached: (vi, vii)                                            provided in accordance with 
                                                                provisions of your company 
                                                                articles and not in fulfilment 
                                                                of the requirements of the 
                                                                Transparency Directive. 
-------------------------------------------------------------  ------------------------------------- 
 
 
 
 8. Notified details: 
-------------------------------------------------------------------------------------------------------------- 
 A: Voting rights attached to shares (viii, ix) 
-------------------------------------------------------------------------------------------------------------- 
 Class/type        Situation previous                 Resulting situation after the 
  of                to the triggering                  triggering transaction 
  shares            transaction 
 
  if possible 
  using 
  the ISIN 
  CODE 
----------------  ---------------------------------  --------------------------------------------------------- 
                   Number             Number          Number        Number of               % of voting 
                    of                 of              of shares     voting                  rights (x) 
                    Shares             Voting                        rights 
                                       Rights 
----------------  -----------------  --------------  ------------  ----------------------  ------------------- 
                                                      Direct        Direct      Indirect    Direct   Indirect 
                                                                     (xi)        (xii) 
----------------   ----------------   -------------  ------------  ----------  ----------  -------  ---------- 
 Ordinary          2,305,769          2,305,769 
  Shares           As per             As per 
                   last               last 
                   TR-1               TR-1 
  FI4000153309     Disclosure         Disclosure      2,271,669     2,139,743   131,926     8.13%    0.50% 
                  -----------------  --------------  ------------  ----------  ----------  -------  ---------- 
 
 
 B: Qualifying Financial Instruments 
-------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
-------------------------------------------------------------------------------------------------------------- 
 Type of            Expiration         Exercise/                    Number of voting        % of voting 
  financial          date               Conversion                   rights that             rights 
  instrument         (xiii)             Period (xiv)                 may be 
                                                                     acquired if 
                                                                     the 
                                                                     instrument 
                                                                     is 
                                                                     exercised/ 
                                                                     converted. 
-----------------  -----------------  ---------------------------  ----------------------  ------------------- 
 
 
 
 
 C: Financial Instruments with similar economic effect 
  to Qualifying Financial Instruments (xv, xvi) 
----------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
----------------------------------------------------------------------------------------------- 
 Type of financial   Exercise   Expiration   Exercise/     Number of voting     % of voting 
  instrument          price      date         Conversion    rights instrument    rights (xix, 
                                 (xvii)       period        refers to            xx) 
                                              (xviii) 
------------------  ---------  -----------  ------------  -------------------  ---------------- 
                                                                                Nominal   Delta 
------------------  ---------  -----------  ------------  -------------------  --------  ------ 
 
 Total (A+B+C) 
----------------------------------------------------------------------------------------------- 
 Number of voting rights                                   Percentage of voting rights 
--------------------------------------------------------  ------------------------------------- 
 2,271,669                                                 8.63% 
--------------------------------------------------------  ------------------------------------- 
 
 
 9. Chain of controlled undertakings through which the 
  voting rights and/or the 
  financial instruments are effectively held, if applicable: 
  (xxi) 
-------------------------------------------------------------------- 
      The voting rights are managed and controlled by Aviva 
       Investors Global Services Limited, with the following 
       chains of controlled undertakings:- 
 
       Aviva Investors Global Services Limited: 
        *    Aviva plc (Parent Company) 
 
 
        *    Aviva Group Holdings Limited (wholly owned subsidiary 
             of Aviva plc) 
 
 
        *    Aviva Investors Holdings Limited (wholly owned 
             subsidiary of Aviva Group Holdings Limited) 
 
 
        *    Aviva Investors Global Services Limited (wholly owned 
             subsidiary of Aviva Investors Holdings Limited) 
 
 Proxy Voting: 
-------------------------------------------------------------------- 
 10. Name of the proxy holder:                     See Section 4 
------------------------------------------------  ------------------ 
 11. Number of voting rights proxy 
  holder will cease 
  to hold: 
------------------------------------------------  ------------------ 
 12. Date on which proxy holder will 
  cease to hold 
  voting rights: 
------------------------------------------------  ------------------ 
 
 
 
  13. Additional information:      Figures are based on a total 
                                   number of voting rights of 

                                   26,311,704 as per the Company's 
                                   Results of Placing and Subscription, 
                                   Issue of Equity and Director/PDMR 
                                   Shareholding Announcement 
                                   of 
                                   21 September 2016. 
-------------------------------  -------------------------------------- 
 14. Contact name:                Neil Whittaker, Aviva plc 
-------------------------------  -------------------------------------- 
 15. Contact telephone number:    00 44 1603 684420 
-------------------------------  -------------------------------------- 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLBUBDGDGGBGLU

(END) Dow Jones Newswires

October 05, 2016 12:10 ET (16:10 GMT)